Who owns Blueprint Medicines?
- Ticker: BPMC
- CUSIP Number: 09627y109
Tip: Access positions for across all investors
Analyze quarterly positions in Blueprint Medicines with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Blueprint Medicines stock
Who bought or sold Blueprint Medicines this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Morgan Stanley | 1.0M | $132M | 100% | Jun 2025 |
|
| FNY Investment Advisers | 41k | $5.3M | 100% | Jun 2025 |
|
| Taylor Investment Counselors | 34k | $4.3M | -3% | Jun 2025 |
|
| DekaBank Deutsche Girozentrale | 26k | $2.5M | 0% | Sep 2025 |
|
| Cibc World Markets | 7.9k | $1.0M | -44% | Jun 2025 |
|
| E Fund Management | 6.8k | $867k | -27% | Jun 2025 |
|
| KBC Group NV | 1.8k | $228k | -35% | Jun 2025 |
|
| Vega Investment Solutions | 310.00 | $40k | -48% | Jun 2025 |
|
| Van Eck Associates Corp. | 132.00 | $17k | -87% | Sep 2025 |
|
| IFP Advisors | 66.00 | $8.5k | 32% | Sep 2025 |
|
| Advisor Group Holdings | 23.00 | $2.9k | -92% | Sep 2025 |
|
| FTB Advisors | 21.00 | $2.7k | 0% | Jun 2025 |
|
| Huntington National Bank | 1.00 | $129.000000 | -100% | Sep 2025 |
|